China’s Biotech Boom Reshapes Pharma, Sparks U.S. Industry Concerns
It appears there’s a China biotech gold rush as U.S. investors and pharma giants look to the world’s second largest economy in a new quest for new drugs and new remedies. Everyone is talking about China right now. Almost 30 percent of Big Pharma deals worth at least $50 million upfront came from China last […]